about
Stent thrombosis in patients treated with thienopyridines: clinical description of 10 casesIslet-1 gene delivery improves myocardial performance after experimental infarctionInhibition of monocyte chemotaxis by VB-201, a small molecule lecinoxoid, hinders atherosclerosis development in ApoE⁻/⁻ mice.Reactivity of peripheral blood lymphocytes to oxidized low-density lipoprotein: a novel system to estimate atherosclerosis employing the Cellscan.Beta2 glycoprotein I containing immune-complexes in lupus patients: association with thrombocytopenia and lipoprotein (a) levels.A study of 20 SLE patients with intravenous immunoglobulin--clinical and serologic response.Circulating apoptotic progenitor cells in patients with congestive heart failure.Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome.Membranous nephropathy in primary antiphospholipid syndrome: description of a case and induction of renal injury in SCID mice.Oxidized low-density lipoprotein (Ox-LDL) but not LDL aggravates the manifestations of experimental antiphospholipid syndrome (APS).Functional properties of antiendothelial cell antibodies.Oral tolerance to low dose beta 2-glycoprotein I: immunomodulation of experimental antiphospholipid syndrome.Circulating autoantibodies to endothelial progenitor cells: binding characteristics and association with risk factors for atherosclerosisInflammatory and immune aspects of atherosclerosis.Autoimmunity in atherosclerosis: lessons from experimental models.Ras inhibition induces insulin sensitivity and glucose uptake.Autoimmunity in atherosclerosis. The role of autoantigens.Deficiency of antigen-presenting cell invariant chain reduces atherosclerosis in mice.Autoantibodies associated with atherosclerosis.Atherosclerosis and autoimmunity.Accelerated atheroma, antiphospholipid antibodies, and the antiphospholipid syndrome.Beta2-glycoprotein I and atherosclerosis.Comparative analysis of the predictive power of different endothelial progenitor cell phenotypes on cardiovascular outcomeThe 106b∼25 microRNA cluster is essential for neovascularization after hindlimb ischaemia in mice.Regulatory T cells influence blood flow recovery in experimental hindlimb ischaemia in an IL-10-dependent manner.Experimental myocardial infarction induces altered regulatory T cell hemostasis, and adoptive transfer attenuates subsequent remodelingInternal thoracic impedance - a useful method for expedient detection and convenient monitoring of pleural effusion.Circulating adiponectin concentrations in patients with congestive heart failure.Circulating Endothelial Progenitor Cells and Clinical Outcome in Patients with Aortic StenosisCirculating endothelial progenitor cells and clinical outcome in patients with congestive heart failure.Circulating endothelial progenitor cells in patients with cardiac syndrome X.The role of erythropoietin in myocardial protection: potential mechanisms and applications.Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project".Anti-oxidized low-density lipoprotein antibodies in chronic heart failure.Circulating CD14(+) monocytes in patients with aortic stenosis.Endothelial progenitor cells as therapeutic vectors in cardiovascular disorders: from experimental models to human trials.Circulating endothelial progenitor cells in cardiovascular disorders.Regulatory T-cells, FoxP3 and atherosclerosis.Modified phospholipids as anti-inflammatory compounds.The prediction of coronary atherosclerosis employing artificial neural networks.
P50
Q28191086-C913A3B2-30ED-4089-A171-0ED00E88F48CQ28513224-94753DB6-6EC3-49B3-B81C-9C1A09BD9D9EQ31123754-B94BA209-B11A-499F-9BB0-6187B8016652Q31401742-79F0BECB-AEB8-4B1C-BB58-A25194486750Q33328443-51C92DBE-B412-4BFE-A3D4-D83C31D7FD6FQ33330951-1C077840-70D2-4CFA-A9D1-991D9A4CC53CQ33370283-5F3DCA02-F9B5-43C2-8BE2-774F2BC93AE4Q33495531-0862292D-D320-4FAF-A46A-B055D7541777Q33498624-151E20F2-9472-4E42-A346-2613B73F1345Q33499323-6E913978-D3AE-453C-89CB-BA5A7FC286D1Q33503920-ADC4B728-F119-475E-8413-287928AE63A1Q33504372-D9A656BD-E384-4553-9367-901ECE3C6FBBQ33778787-1B03D587-9447-478F-9D07-6FE0C8197046Q33872000-FFD5FD38-1BD8-46C8-91F0-D2ECB9C636FFQ33915478-8917E9D0-5A64-4657-9136-EB117C7109FBQ33955305-B8433D60-D0A5-4EE4-9092-257A74AA7036Q33976585-DCB1885B-C8ED-454B-A021-79419E811230Q34082315-E8E0BCDF-70D2-4678-AA57-F5D4B57865B9Q34157599-DF38430C-10B2-4217-B0F2-DCA449638F54Q34243799-2CD81A5D-6BB5-4CB1-9BE1-6CCCEC0411B6Q34354736-543B071B-2C07-4B32-879C-1B5613044171Q34372303-C0D96648-F9CE-4A72-971F-883153F20D20Q34389649-EAB98796-1D2D-424D-A3C4-9CEBA9B75A3DQ34591260-C52AFCB4-8DED-46E8-A08E-893D1AD4CB7BQ35195128-78F93ACC-E0A0-4A16-87AB-551156D27543Q35462957-58DF6F11-04FE-4371-B4E1-9FB0B51D2576Q35546902-234877DB-F8A0-4E35-940B-0696B2213A3AQ35772024-59D49844-4971-435E-9C51-DBC11D80D354Q35935375-62560AB5-91E2-4765-8D06-257A371F2407Q35954189-B68A8F67-F2AF-49DC-8441-C75ED0E592C5Q35954256-1CD39A0A-9350-4FBB-8059-C0ADB46E80BFQ36352011-E3326E25-ABB3-4AB3-A46C-46EE4B60CA69Q36399103-A41ED247-F735-4BEF-BEE7-330841A7DD9DQ36421852-371DF442-F15A-4A3C-93FE-64E8E586A2BEQ36578461-AA12B16A-CD00-4FFC-99CA-84CAEBC998B4Q36851576-951DF387-D6E4-49AA-9ACD-2F4B4689820CQ37269391-6F4A8B1B-2109-4CA4-A0BE-96953A79B2A2Q37739367-81899A64-1F60-49DA-A6C2-24DB86422B2DQ37786505-32F3F141-0FD7-4185-9E77-26EDD4CC6670Q37876166-12A92BC8-5DE6-44AC-B284-41A1AE004647
P50
description
forsker
@nb
researcher
@en
name
Jacob George
@da
Jacob George
@de
Jacob George
@en
Jacob George
@nb
Jacob George
@nl
type
label
Jacob George
@da
Jacob George
@de
Jacob George
@en
Jacob George
@nb
Jacob George
@nl
prefLabel
Jacob George
@da
Jacob George
@de
Jacob George
@en
Jacob George
@nb
Jacob George
@nl
P106
P2038
Jacob_George9